US Bancorp
PDSB icon

US Bancorp’s PDS Biotechnology PDSB Stock Holding History

US Bancorp’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,084
Closed -$10.5K – 4084
2023
Q2 		$10.5K Hold
2,084
– – ﹤0.01% 3239
2023
Q1 		$12.8K Hold
2,084
– – ﹤0.01% 3188
2022
Q4 		$27.5K Hold
2,084
– – ﹤0.01% 2831
2022
Q3 		$6K Buy
2,084
+1,000
+92% +$4.24K ﹤0.01% 3548
2022
Q2 		$4K Buy
+1,084
New +$5.15K ﹤0.01% 3658

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's PDSB Position: Q3 2023 in Review

US Bancorp sold out of PDS Biotechnology (PDSB) in Q3 2023, closing a stake of 2,084 shares — an estimated $10.5K sold.

US Bancorp first reported a position in PDSB in Q2 2022 and held it in 5 quarters. The position peaked at $27.5K in Q4 2022. 78 funds tracked by Wall St. Rank hold PDSB as of Q3 2023.

  • US Bancorp reported no remaining PDS Biotechnology position as of Q3 2023 after selling out during the quarter.
  • US Bancorp sold 2,084 PDS Biotechnology shares in Q3 2023, an estimated $10.5K.
  • US Bancorp first reported a position in PDS Biotechnology in Q2 2022 and held it in 5 quarters.
  • US Bancorp's PDS Biotechnology position peaked at $27.5K in Q4 2022.
  • 78 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2023.

Based on US Bancorp's 13F filing for Q3 2023, filed 3 Nov 2023.